Search Results for "establish"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for establish. Results 151 to 160 of 654 total matches.
Laser Coronary Angioplasty
The Medical Letter on Drugs and Therapeutics • Jan 25, 1991 (Issue 836)
an established therapeutic
option for treatment of patients with coronary artery disease, especially those ...
Percutaneous transluminal coronary angioplasty (PTCA), in which a balloon catheter distends the vessel at the site of obstruction (Medical Letter, 25:97, 1983), is now an established therapeutic option for treatment of patients with coronary artery disease, especially those with single-vessel disease. Major problems related to PTCA include acute occlusion during the procedure (usually caused by dissection), restenosis at the site of angioplasty, and inability to treat complete occlusions and long or ostial lesions. Some cardiologists have tried using lasers during PTCA to deal with these...
FK 506 - An Investigational Immunosuppressant
The Medical Letter on Drugs and Therapeutics • Oct 04, 1991 (Issue 854)
during transplantation, the drug’s relative effectiveness and toxicity remain to be established ...
FK 506 (Fujisawa), an immunosuppressant similar in activity to cyclosporine (Sandimmune - Medical Letter 25:77, 1983), is currently under investigation in the USA, Europe, and Japan for prevention of organ transplant rejection.
Alpha-Galactosidase to Prevent Gas
The Medical Letter on Drugs and Therapeutics • Apr 02, 1993 (Issue 893)
of the doses recommended has
not been established.
THE MEDICAL LETTER (ISSN 1523-2859) is published ...
The enzyme alpha-galactosidase (Beano - AkPharma), derived from a mold and classified as a food, is sold without presecription in pharmacies and food stores. The manufacturer recommends taking the anzyme to decrease intestinal gas producted by eating the high-fiber diets now widely recommended in the USA.
Drugs for Acute Spinal Cord Injury
The Medical Letter on Drugs and Therapeutics • Aug 06, 1993 (Issue 902)
ganglioside
could provide additional benefit and is safe remains to be established.
THE MEDICAL LETTER ...
The well-publicized recovery from paralysis of a professional football player has recently focused attention on the growing use of drugs to minimize the effects of spinal cord injury. Methylprednisolone sodium succinate (Solu-Medrol - Upjohn), commercially available in the USA for intravenous treatment of transplant rejection and various inflammatory and auto-immune disorders, and GM-1 ganglioside, commercially available in Italy (Sygen - Fidia) but not in the USA, are now widely used in patients with spinal cord injury.
Home Testing of Cholesterol
The Medical Letter on Drugs and Therapeutics • Sep 30, 1994 (Issue 932)
public remains to be established.
THE MEDICAL LETTER (ISSN 1523-2859) is published and printed ...
The new Advanced Care Cholesterol Test (Johnson & Johnson) now being advertised to the general public encourages patients to test their own serum cholesterol concentrations. Approved by the US Food and Drug Administration, this product is available in pharmacies without a prescription at a cost of about $20 for a single determination.
Pegaspargase for Acute Lymphoblastic Leukemia
The Medical Letter on Drugs and Therapeutics • Mar 17, 1995 (Issue 944)
of asparaginase and pegaspargase remain to be established.
THE MEDICAL LETTER (ISSN 1523-2859) is published ...
Pegaspargase (peg as par jase; PEG-L-asparaginase; Oncaspar - Rh ne-Poulenc Rorer), a polyethylene glycol (PEG) conjugate of L-asparaginase, has been approved by the US Food and Drug Administration for treatment of acute lymphoblastic leukemia (ALL), the most common malignancy of childhood. The new drug is recommended only for patients who have had allergic reactions to asparaginase. Asparaginase is available commercially as Elspar, which is derived from Escherichia coli. A formulation derived from Erwinia chrysanthemi is available on an investigational basis (Ogden Bioservices,...
Bicalutamide for Prostate Cancer
The Medical Letter on Drugs and Therapeutics • Jun 21, 1996 (Issue 977)
is as effective as flutamide in preventing disease flare has not been established. Whether the addition of any ...
Bicalutamide (Casodex - Zeneca), an oral nonsteroidal antiandrogen similar to flutamide (Eulexin - Medical Letter, 31:72, 1989), is now available in the USA for treat-ment of advanced prostate cancer. The drug is recommended by the manufacturer for use concurrently with an analog of luteinizing hormone-releasing hormone (LHRH) such as leuprolide (Lupron; Lupron Depot) or goserelin (Zoladex -Medical Letter, 32:102, 1990).
Raloxifene for Postmenopausal Osteoporosis
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998 (Issue 1022)
and effectiveness of the drug have not
been established, and direct comparisons with other drugs are lacking ...
Raloxifene (Evista - Lilly), a benzothiophene that acts on estrogen receptors, has recently been marketed for prevention of postmenopausal osteoporosis. Only estrogen (alone or in combination with a progestin) and the bisphosphonate alendronate (Fosamax) were previously approved by the FDA for this indication.
Sibutramine for Obesity
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998 (Issue 1022)
of sibutramine, but the clinical significance of these elevations has not been established. Sibutramine should ...
Sibutramine hydrochlorid monohydreate (Meridia - Knoll), which is structurally related to amphetamine, has been approved by the FDA for treatment of obesity. It is classified by the Drug Enforcement Agency (DEA) as a schedule IV controlled substance.
In Brief: Plan B OTC
The Medical Letter on Drugs and Therapeutics • Sep 11, 2006 (Issue 1243)
. The drug will not terminate an established pregnancy. No fetal malformations
have been reported after ...
The FDA has approved over-the-counter (OTC) sales of Plan B (Duramed), an emergency contraceptive package that contains two 0.75-mg tablets of levonorgestrel, to women ≥18 years old. Younger women still require a prescription. In one trial, two levonorgestrel 0.75-mg tablets taken 12 hours apart, the first within 72 hours after unprotected intercourse, decreased the pregnancy rate to 1%, compared to an expected rate of 8% (Task Force on Postovulatory Methods of Fertility Regulation, Lancet 1998; 352:428). How high doses of a progestin taken after coitus prevent pregnancy is unclear; they may...